Family-Based Whole-Genome Sequencing to Identify Cancer Risk in Children and Adolescents Newly Diagnosed with Cancer
Led by Sydney Children's Hospitals Network · Updated on 2022-11-04
270
Participants Needed
3
Research Sites
275 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the usefulness of family-based whole-genome sequencing WGS to identify cancer predisposition syndromes CPS in children and adolescents newly diagnosed with cancer. These syndromes are caused by inherited mutations in cancer predisposition genes and are linked to a higher risk of developing certain cancers. The study aims to understand how often CPS occurs in this population and the impact of germline sequencing on patients and their families. This is a multicenter prospective observational study focusing on clinical benefits and utility of WGS compared to traditional clinical information.
Participants will undergo family-based germline whole-genome sequencing to identify genetic variants related to cancer predisposition. The results will be discussed in multidisciplinary meetings, and referrals to Cancer Genetics Clinics for further evaluation and genetic counseling may be recommended. Additionally, the study includes a psychosocial component to assess how the sequencing process affects patients and their families. The study follows patients for up to five years to analyze psychological impact and cost-effectiveness.
During the study, researchers will collect detailed family cancer histories and monitor genetic findings, including inherited and new mutations. The primary outcome measures focus on comparing the detection of CPS by WGS versus clinical factors over two years. Secondary outcomes include mutation types, test turnaround times, surveillance adherence, and psychological effects assessed over five years. Participants will be closely followed to evaluate diagnostic accuracy, genetic counseling outcomes, and the broader impact of sequencing on care and family well-being.
CONDITIONS
Brief Title
Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed Cancer
Research Team
C
Clinical Trials Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Up to 2 years
Participants undergo family-based whole genome sequencing to identify cancer predisposition syndromes and related genetic variants.
1 baseline visit with genetic testing and family history collection
Long-term Monitoring
Duration - Up to 5 years
Participants and their families are followed to assess the psychosocial impact of germline sequencing and to monitor clinical outcomes related to cancer predisposition.
Additional visits depending on genetic findings and follow-up needs
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Phase III Study of Oral Zotiraciclib for Recurrent Malignant Gliomas with IDH1 or IDH2 Mutations
Study of 18F-FAPI-04 PETCT and PETMR Scans for Detecting and Monitoring Various Cancers
18F-grazy-02 PETCT Imaging to Monitor Immunotherapy Responses in Adults with Lung Cancer or Melanoma
Study of 68Ga-NYM096 PETCT Imaging to Measure Tracer Uptake in Different Types of Cancer Including Primary and Metastatic Tumors
PET Imaging Using 68GaGa-Sa-DABI-4 to Detect Stimulator of Interferon Gene Expression in Adults with Cancer
Behavioral Intervention to Help Young LatinoHispanic Men with Cancer Manage Emotions and Life Goals
Prospective Clinical and Biological Database of Cancer Patients Starting Anticancer Immunotherapy
Tracking Immune-Related Side Effects Over Time
Phase I Trial Evaluating Safety and Dose of PA5 Intravenous Treatment for Adults With Advanced Solid Tumors
Online Platform for Sharing Cancer Patient Information
To Support Treatment Decisions and Accelerate Research
Study of a Decision Support Program for Older Adults 60 with Acute Myeloid Leukemia and Their Caregivers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study.